(NBSE) – FDA
-
NeuBase Therapeutics (NBSE) Announces Gene Editing Research Agreement with Global Healthcare Company
-
NeuBase Therapeutics (NBSE) Demonstrates Functional Rescue in Myotonic Dystrophy Type 1 Model and Allele-Selective Inhibition of KRAS Mutations to Inhibit Tumor Growth
-
Back to NBSE Stock Lookup